Učitavanje...
Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer
Background/Aim: Oncotype DX recurrence score (RS) for breast cancer is a useful tool for determining chemotherapy indication but it is expensive and time-consuming. We determined whether four immuno-histochemical markers, namely human epidermal growth factor 2 (HER2), estrogen receptor (ER), progest...
Spremljeno u:
| Izdano u: | In Vivo |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
International Institute of Anticancer Research
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286534/ https://ncbi.nlm.nih.gov/pubmed/34182528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12522 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|